Deferasirox – a rarer cause of Fanconi syndrome
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2019.1650592
Abstract: ABSTRACT Deferasirox is a recently approved iron chelator and is widely used to treat iron overload in transfusion-dependent patients. Its once-daily dosing and oral route of administration have made it an appealing alternative to deferoxamine.… read more here.
Keywords: rarer cause; cause fanconi; deferasirox rarer; deferasirox ... See more keywords